(S (NP (QP (IN Over) (PDT half) (DT a) (CD million)) (NNS individuals)) (VP (VBP are) (VP (VBN diagnosed) (PP (IN with) (NP (NN head) (CC and) (NN neck) (NN cancer))) (NP (DT each) (NN year)) (ADVP (RB worldwide)))) (. .))
(S (S (NP (NNP Radiotherapy)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN curative) (NN treatment)) (PP (IN for) (NP (DT this) (NN disease)))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ requires) (NP (NP (ADJP (RB manually) (JJ intensive)) (NN delineation)) (PP (IN of) (NP (NP (NP (JJ radiosensitive) (NNS organs)) (PP (IN at) (NP (NN risk)))) (PRN (-LRB- -LRB-) (NP (NNP OARs)) (-RRB- -RRB-))))))) (. .))
(S (NP (DT This) (NN planning) (NN process)) (VP (MD can) (VP (VB delay) (NP (NN treatment) (NN commencement)))) (. .))
(S (SBAR (IN While) (S (NP (JJ auto-segmentation) (NN algorithms)) (VP (NN offer) (NP (DT a) (ADJP (RB potentially) (JJ time-saving)) (NN solution))))) (, ,) (NP (NP (DT the) (NNS challenges)) (PP (IN in) (S (VP (NN defining) (, ,) (VBG quantifying) (CC and) (VBG achieving) (NP (JJ expert) (NN performance)))))) (VP (NN remain)) (. .))
(S (S (VP (VBG Adopting) (NP (DT a) (JJ deep) (NN learning) (NN approach)))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT a) (CD 3D) (JJ U-Net) (NN architecture)) (SBAR (WHNP (WDT that)) (S (VP (VBZ achieves) (NP (NP (NN performance)) (ADJP (JJ similar) (PP (TO to) (NP (NP (NNS experts)) (PP (IN in) (S (VP (VBG delineating) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN head) (CC and) (NN neck) (NNP OARs)))))))))))))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBD was) (VP (VBN trained) (PP (IN on) (NP (NP (DT a) (NN dataset)) (PP (IN of) (NP (NP (CD 663) (JJ deidentified) (VBN computed) (NN tomography) (PRN (-LRB- -LRB-) (NNP CT) (-RRB- -RRB-)) (VBZ scans)) (VP (VP (VBN acquired) (PP (IN in) (NP (JJ routine) (JJ clinical) (NN practice)))) (CC and) (VP (VBD segmented) (PP (VBG according) (PP (TO to) (NP (NN consensus) (NNP OAR) (NNS definitions)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (NP (PRP$ its) (NN generalisability)) (PP (IN through) (NP (NP (NN application)) (PP (TO to) (NP (NP (DT an) (JJ independent) (NN test) (NN set)) (PP (IN of) (NP (NP (NP (CD 24) (NNP CT) (NNS scans)) (ADJP (JJ available) (PP (IN from) (NP (NP (DT The) (NNP Cancer) (NNP Imaging) (NNP Archive)) (VP (VBD collected) (PP (IN at) (NP (NP (JJ multiple) (JJ international) (NNS sites)) (ADJP (RB previously) (JJ unseen) (PP (TO to) (NP (DT the) (NN model))))))))))) (, ,) (NP (NP (DT each)) (VP (VP (VBN segmented) (PP (IN by) (NP (CD two) (JJ independent) (NNS experts)))) (CC and) (VP (VBG consisting) (PP (IN of) (NP (NP (CD 21) (NNP OARs)) (VP (ADVP (RB commonly)) (VBD segmented) (PP (IN in) (NP (JJ clinical) (NN practice)))))))))))))))) (. .))
(S (PP (IN With) (NP (JJ appropriate) (NX (NX (NN validation) (NNS studies)) (CC and) (NX (JJ regulatory) (NNS approvals))))) (, ,) (NP (DT this) (NN system)) (VP (MD could) (VP (VB improve) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NN radiotherapy) (NNS pathways)))))) (. .))
